Patents

US 12723249 B2: AAV production strategy using a cell line expressing an inducible rep gene

Granted
2026-09-01
Filed
2020-10-14 application 17767962
Type
Utility · 3 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Aspects of the disclosure relate to manufacturing AAV using a stable cell line that expresses the rep gene by engineering tRNA to suppress a mutation introduced to a rep integrated into the genome of the cell line.

Source: PTBLXML, file of 2026-09-01 (ipgb20260901.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
University of Massachusetts 1,152 patentsUS company or organizationWestborough, MAUNIVERSITY OF MASSACHUSETTS Federal lobbying client EXACT high confidence: identical full name and statePTBLXML, file of 2026-09-01

Inventors

InventorPlacePatentsPerson pageSource
Guangping GaoWorcester, MA111PTBLXML, file of 2026-09-01
Dan WangWorcester, MA45PTBLXML, file of 2026-09-01
Jote BulchaWorcester, MAPTBLXML, file of 2026-09-01

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/52PTBLXML, file of 2026-09-01
C07KPeptidesC07K14/005PTBLXML, file of 2026-09-01

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.